These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 9382963)

  • 1. Plasma levels and hepatic mRNA expression of transforming growth factor-beta1 in patients with fulminant hepatic failure.
    Miwa Y; Harrison PM; Farzaneh F; Langley PG; Williams R; Hughes RD
    J Hepatol; 1997 Nov; 27(5):780-8. PubMed ID: 9382963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma hepatocyte growth factor and biliprotein levels and outcome in fulminant hepatic failure.
    Hughes RD; Zhang L; Tsubouchi H; Daikuhara Y; Williams R
    J Hepatol; 1994 Jan; 20(1):106-11. PubMed ID: 8201209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioartificial liver treatment in rats with fulminant hepatic failure: effect on DNA-binding activity of liver-enriched and growth-associated transcription factors.
    Suh KS; Lilja H; Kamohara Y; Eguchi S; Arkadopoulos N; Neuman T; Demetriou AA; Rozga J
    J Surg Res; 1999 Aug; 85(2):243-50. PubMed ID: 10423325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss and recovery of liver regeneration in rats with fulminant hepatic failure.
    Eguchi S; Lilja H; Hewitt WR; Middleton Y; Demetriou AA; Rozga J
    J Surg Res; 1997 Oct; 72(2):112-22. PubMed ID: 9356231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coagulation factor V and VIII/V ratio as predictors of outcome in paracetamol induced fulminant hepatic failure: relation to other prognostic indicators.
    Pereira LM; Langley PG; Hayllar KM; Tredger JM; Williams R
    Gut; 1992 Jan; 33(1):98-102. PubMed ID: 1740285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced plasma transforming growth factor-beta1 levels in patients with chronic hepatitis C after interferon-alpha therapy: association with regression of hepatic fibrosis.
    Tsushima H; Kawata S; Tamura S; Ito N; Shirai Y; Kiso S; Doi Y; Yamada A; Oshikawa O; Matsuzawa Y
    J Hepatol; 1999 Jan; 30(1):1-7. PubMed ID: 9927144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nephromegaly and elevated plasma hepatocyte growth factor-transforming growth factor-beta1 ratio in infants with fulminant hepatitis or biliary atresia.
    Tsau YK; Lu MY; Ni YH
    Am J Kidney Dis; 2001 Aug; 38(2):279-85. PubMed ID: 11479153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Up-regulation of hepatocyte growth factor caused by an over-expression of transforming growth factor beta, in the rat model of fulminant hepatic failure.
    Nozato E; Shiraishi M; Nishimaki T
    J Surg Res; 2003 Dec; 115(2):226-34. PubMed ID: 14697288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Digoxin-like immunoreactive substances in severe acute liver disease due to viral hepatitis and paracetamol overdose.
    Yang SS; Hughes RD; Williams R
    Hepatology; 1988; 8(1):93-7. PubMed ID: 2828215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activin A and follistatin in acute liver failure.
    Hughes RD; Evans LW
    Eur J Gastroenterol Hepatol; 2003 Feb; 15(2):127-31. PubMed ID: 12560755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum level of transforming growth factor-beta1 (TGF-beta1) and the expression of TGF-beta receptor type II in peripheral blood mononuclear cells in patients with autoimmune hepatitis.
    Sakaguchi K; Kitano M; Nishimura M; Senoh T; Ohta T; Terao M; Shinji N; Koide N; Tsuji T
    Hepatogastroenterology; 2004; 51(60):1780-3. PubMed ID: 15532825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombin-antithrombin III complex in fulminant hepatic failure: evidence for disseminated intravascular coagulation and relationship to outcome.
    Langley PG; Forbes A; Hughes RD; Williams R
    Eur J Clin Invest; 1990 Dec; 20(6):627-31. PubMed ID: 2127751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of human hepatocyte growth factor in blood from patients with fulminant hepatic failure.
    Tsubouchi H; Hirono S; Gohda E; Nakayama H; Takahashi K; Sakiyama O; Miyazaki H; Sugihara J; Tomita E; Muto Y
    Hepatology; 1989 Jun; 9(6):875-81. PubMed ID: 2523850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocyte growth factor and transforming growth factor beta1 contribute to regeneration of small-for-size liver graft immediately after transplantation.
    Ninomiya M; Harada N; Shiotani S; Hiroshige S; Minagawa R; Soejima Y; Suehiro T; Nishizaki T; Shimada M; Sugimachi K
    Transpl Int; 2003 Nov; 16(11):814-9. PubMed ID: 12879228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming growth factor-beta1 in plasma and liver of children with liver disease.
    Rosensweig JN; Omori M; Page K; Potter CJ; Perlman EJ; Thorgeirsson SS; Schwarz KB
    Pediatr Res; 1998 Sep; 44(3):402-9. PubMed ID: 9727721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extent of the acute phase response in fulminant hepatic failure.
    Izumi S; Hughes RD; Langley PG; Pernambuco JR; Williams R
    Gut; 1994 Jul; 35(7):982-6. PubMed ID: 8063228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term effect of hepatocyte transplantation on fulminant hepatic failure in rats.
    Ahmad TA; Fujioka H; Eguchi S; Yanaga K; Kamohara Y; Furui J; Kanematsu T
    Hepatogastroenterology; 2003; 50(50):467-71. PubMed ID: 12749249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic expression of hepatocyte-growth-factor-like/macrophage-stimulating protein mRNA in fulminant hepatic failure.
    Harrison P; Degen SJ; Williams R; Farzaneh F
    Lancet; 1994 Jul; 344(8914):27-9. PubMed ID: 7912298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective study of plasma fibronectin in fulminant hepatitis: association with infection and mortality.
    Acharya SK; Dasarathy S; Irshad M
    J Hepatol; 1995 Jul; 23(1):8-13. PubMed ID: 8530814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fulminant hepatic failure in rats: survival and effect on blood chemistry and liver regeneration.
    Eguchi S; Kamlot A; Ljubimova J; Hewitt WR; Lebow LT; Demetriou AA; Rozga J
    Hepatology; 1996 Dec; 24(6):1452-9. PubMed ID: 8938180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.